Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-16-001574
Filing Date
2016-02-10
Accepted
2016-02-10 15:31:08
Documents
1
Period of Report
2016-02-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4286
  Complete submission text file 0001562180-16-001574.txt   5639
Mailing Address ROBERTS SHERIDAN & KOTEL 12 EAST 49TH STREET 30TH FL NEW YORK NY 10017
Business Address
JONAS JEFFREY M (Reporting) CIK: 0001042021 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36544 | Film No.: 161405459

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Issuer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations